Freyr Supported Regulatory Transfer and K-DMF Holding in South Korea for a Hungary-Based Pharmaceutical Company

Client Overview

A Hungary-based pharmaceutical company required Regulatory operations support for its Active Pharmaceutical Ingredient (API) in South Korea. The client sought assistance with Regulatory transfer activities and K-DMF holding to ensure continued compliance and seamless Regulatory management within the South Korean market.

Background

As part of its Regulatory strategy in South Korea, the client needed to complete a Regulatory transfer and establish K-DMF holding arrangements for its API. However, uncertainty around the required sequence of activities and documentation requirements created challenges that could potentially impact timelines and Regulatory compliance. The client required expert guidance to navigate the process efficiently while ensuring alignment with MFDS expectations.

Services in Scope

Regulatory transfer support in South Korea

K-DMF holding support

Regulatory strategy and process planning

Documentation assessment and preparation support

Regulatory compliance guidance

MFDS coordination support

Challenge

The client faced uncertainty regarding the appropriate sequence of Regulatory activities, particularly whether the Marketing Authorization (MA) transfer should be completed before addressing pending variations.

This lack of clarity created concerns about potential delays and Regulatory complications.

In addition, the client was unsure about the documentation requirements associated with each stage of the process.

Without a clear understanding of the necessary submissions and supporting documents, there was a risk of inefficiencies, rework, and non-compliance with MFDS expectations.

Solution

Freyr conducted a detailed assessment of the client's Regulatory requirements and provided strategic guidance on the optimal sequence of activities to ensure a smooth and compliant transition.

Based on the Regulatory landscape and project objectives, Freyr recommended a comprehensive approach that minimized the risk of approval delays and procedural complications.

The team also assisted the client in identifying, organizing, and preparing the documentation required for both the MA transfer and associated variation activities.

By establishing a clear Regulatory roadmap and ensuring documentation readiness, Freyr helped streamline the overall process while maintaining compliance with applicable MFDS requirements.

Impact

Through its Regulatory expertise and structured approach, Freyr enabled the client to execute Regulatory transfer and K-DMF holding activities with greater confidence, clarity, and efficiency. The engagement reduced uncertainty, strengthened compliance readiness, and helped ensure a smoother interaction with South Korean Regulatory authorities.